Enduring Material

• The Northeast Ohio Medical University designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
• The Northeast Ohio Medical University designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Northeast Ohio Medical University designates this enduring material for a maximum of 1 Hour(s) Social Work. Participants should claim only the credit commensurate with the extent of their participation in the activity.
• The Northeast Ohio Medical University designates this enduring material for a maximum of 1 Credit(s) Counselor Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
• The Northeast Ohio Medical University designates this enduring material for a maximum of 1 Hour(s) OPA-MCE. Participants should claim only the credit commensurate with the extent of their participation in the activity.
• The Northeast Ohio Medical University designates this enduring material for a maximum of 1 Hour(s) OCDP. Participants should claim only the credit commensurate with the extent of their participation in the activity.

This module provides practical guidance, case studies, and legal insights to help you integrate evidence-based treatments effectively into your practice.
Disclosure of Relevant Financial Relationships
Everyone involved in the planning, reviewing and teaching of this activity was required to complete a disclosure form indicating all relevant financial relationships with any ‘commercial interest’. A ‘commercial interest’ is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. This is done so that the audience can determine whether an individual’s relationships may influence the presentations.
The faculty, reviewers and planners of this activity have disclosed there are no relevant financial relationships with any ‘commercial interests’.

Christina Delos Reyes, MD and Sybil Marsh, MD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Stacey Gardner-Buckshaw, PhD, Nichole Ammon, LPCC, M.S. Ed., PCC-S, John Ellis, MSW, LICDC-CS, ICCS, Christina Delos Reyes, MD, Sara Dugan, PharmD, and Jessica Zavala, MPA have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Sara Dugan, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: There are limited treatment options that have FDA approval for the indication of aggression therefore discussion of treatment is usually inclusive of off label treatments.

• Northeast Ohio Medical University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.

70 %

100 %

6/18/2025